Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Vascular Surgery
  •  Breast Surgery
  •  Transplant Surgery
  •  Pediatric Surgery
  •  Neurological Surgery
  •  Oral and Maxillofacial Surgery
  •  Thoracic Surgery
  •  Bariatric Surgery

Abstract

Citation: Clin Surg. 2020;5(1):2965.Research Article | Open Access

Impact and Counter Measures of COVID-19 Nosocomial Infection on Upper Gastrointestinal Surgery

Fumiaki Yano*, Takahiro Masuda, Masami Yuda, Yuichiro Tanishima, Katsunori Nishikawa, Muneharu Fujisaki, Norio Mitsumori, Takashi Ohtsuka, Toru Ikegami and Takao Ohki

Department of Surgery, Jikei University School of Medicine, Tokyo, Japan

*Correspondance to: Fumiaki Yano 

 PDF  Full Text DOI: 10.25107/2474-1647.2965

Abstract

Objectives: The Jikei University Hospital (JKUH) declared a hospital-wide state of emergency on 4th April 2020, the day after confirming its first COVID-19 nosocomial infections, generally suspending first-time outpatient consultations, new admissions, and non-urgent procedures and tests. This report details how upper gastrointestinal surgeries at JKUH were affected by the COVID-19 pandemic. Methods: The records of 103 patients scheduled for elective surgery to treat an upper gastrointestinal disease or condition at JKUH between January and April 2020 were reviewed to assess our institution?s response and areas for improvement. Results: Starting 20th April, all inbound patients were screened for COVID-19 through RT-PCR and chest CT, a policy that successfully prevented new nosocomial infections from asymptomatic carriers. 80.0% of the scheduled surgeries were performed as planned (n=82), none of whom were COVID-19-positive. However, 20.0% (n=21) of the procedures had to be postponed, 38.1% (n=8) of which were to treat malignant disease. Five of them were postponed despite their malignancy due to the need to ensure sufficient availability of ICU beds. In addition, our gastrointestinal surgery division decided to cancel all operations to treat benign conditions in the pandemic?s wake; however, the quality-of-life reductions experienced by patients with achalasia or GERD - comprising 85% of the cases - are hard to reconcile with a designation of ?non-urgent?. Conclusion: The COVID-19 pandemic forced our department to postpone 20% of the scheduled upper gastrointestinal surgeries. Surgery was still indicated for all cases, and those designated as ?non-urgent? would nonetheless have benefited from quicker intervention.

Keywords

COVID-19; SARS-CoV-2; 2019-nCoV; Coronavirus; Nosocomial infection; Gastrointestinal surgery; UGI surgery

Cite the article

Yano F, Masuda T, Yuda M, Tanishima Y, Nishikawa K, Fujisaki M, et al. Impact and Counter Measures of COVID-19 Nosocomial Infection on Upper Gastrointestinal Surgery. Clin Surg. 2020; 5: 2965.

Search Our Journal

Journal Indexed In

Articles in PubMed

Automated Sagittal Craniosynostosis Classification from CT Images Using Transfer Learning
 PubMed  PMC  PDF  Full Text
Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Blockage of Schlemm’s Canal Orifice after Ab-Interno Canaloplasty Surgery for Glaucoma
 Abstract  PDF  Full Text
Prognosis of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty versus Bare Nitinol Stent Angioplasty for Femoropopliteal Arteriosclerosis Obliterans: A Retrospective Cohort Study
 Abstract  PDF  Full Text
View More...